Drug Profile
Trabectedin companion diagnostic - Myriad Genetics
Alternative Names: BRACAnalysis (Trabectedin); Trabectedin - BRACAnalysisLatest Information Update: 16 Mar 2017
Price :
$50
*
At a glance
- Originator Myriad Genetics
- Developer Janssen Research & Development; Myriad Genetics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
Most Recent Events
- 16 Mar 2017 No recent reports on development identified - Phase-III for Peritoneal cancer (Diagnosis), Ovarian cancer (Diagnosis), Fallopian tube cancer (Diagnosis) in China, Israel, New Zealand, Russia, Switzerland, United Kingdom, South Africa, Australia, USA (unspecified route)
- 01 Oct 2014 Phase-III clinical trials in Fallopian tube cancer (Diagnosis) in USA, Australia, China, Israel, New Zealand, Russia, South Africa, Switzerland and United Kingdom (unspecified route)
- 01 Oct 2014 Phase-III clinical trials in Ovarian cancer (Diagnosis) in USA, Australia, China, Israel, New Zealand, Russia, South Africa, Switzerland and United Kingdom (unspecified route)